4 resultados
Hemodialysis (HD) is the most worldwide prescribed renal replacement therapy for patients with end-stage renal disease. This treatment that relies heavily on technology has undergone major modifications in the last five decades in order to improve patients' outcomes. Those changes that aimed at
Hypothesis
Our hypothesis is that HDx is noninferior to olHDF in the following parameters:
- Hemodynamic stability
- Nutritional and fluid status
- Removal of beta-2 microglobulin
Objectives To evaluate each patient, through a prospective, randomized and cross-over study, the intradialytic
1. Study Design:
Randomized-controlled study of all type 2 DM patients in dialysis to assess the effect of two different dialysate glucose concentrations, standard 5.5 mmol/L and high 10 mmol/L. The study period will be 20 weeks-4 weeks for recruitment, 12 weeks for the intervention and 4 weeks of
A Study Of The Effect Of Hemodialysis Vascular Access Type On Markers Of Inflammation PI: Michele H. Mokrzycki MD, MS
Introduction/Background: The prevalence of chronic inflammation is high (35-65%) in end stage renal disease (ESRD) patients and is associated with an increased risk of